Table 2

Correlations of γ-synuclein expression with clinic pathological factors of endometrioid endometrial carcinoma

	Case, n	γ-Synuclein		χ²	p Value
	Case, n	Positive	%	χ²	p Value
Age				0.007	0.935
<50	21	10	47.6
≥50	39	19	48.7
Stage^*					0.01^†
I	26	7	26.9
II	10	6	60.0
III	23	15	65.2
IV	1	1	100.0
Grade				0.995	0.608
G1	22	9	40.9
G2	26	13	50.0
G3	12	7	58.3
Lymph node metastasis				0.02^†
Positive	6	6	100.0
Negative	31	14	45.2
Depth of endometrial invasion			14.322	0.000
<1/2	41	13	31.7
≧1/2	19	16	84.2
ER status				0.537	0.464
Negative	18	10	55.6
Positive	42	19	45.2
PR status				1.115	0.291
Negative	15	8	53.3
Positive	45	21	38.2

↵* The difference between stage I versus stage II and stage III versus stage IV were not significant, so we used the χ² segmentation method and we found that the difference of γ-synuclein between stage I/II versus III/IV was significant (p=0.020).
↵† Fischer's exact test.